| Trial Identifier: | D5670C00013 |
| Sponsor: | MedImmune, LLC |
| NCTID:: | NCT03550378 |
| Start Date: | June 2018 |
| Primary Completion Date: | February 2019 |
| Study Completion Date: | February 2019 |
| Condition: | Kidney Diseases; Diabetes: Type 2 |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
| Language | Description |
| English Translation | |
| German Translation |
| Country | Location |
|---|---|
| Germany | Berlin, Germany, 10117 |
| Germany | Dusseldorf, Germany, 40210 |
| Germany | Magdeburg, Germany, 39120 |
| Germany | München, Germany, 81241 |
| Germany | Munster, Germany, 48145 |
| United Kingdom | Airdrie, United Kingdom, ML6 0JS |
| United Kingdom | Dundee, United Kingdom, DD1 9SY |
| United Kingdom | Edinburgh, United Kingdom, EH16 4SA |
| United Kingdom | Edinburgh, United Kingdom, EH4 2XU |
| United Kingdom | Glasgow, United Kingdom, G75 8RG |
| United Kingdom | Kirkaldy, United Kingdom, KY2 5AH |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2024 Pharma Intelligence UK Limited (Citeline), a Norstella company